Effect of ginseng in reducing the severity of fatigue in individuals with idiopathic chronic fatigue

Assessing the effect of ginseng in reducing the severity of fatigue in individuals with idiopathic chronic fatigue

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20140804018677N20

Enrollment

Registered

2022-05-17

Start date

2022-05-05

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic fatigue. Chronic fatigue, unspecified

Interventions

Intervention 1: Intervention group: 500 mg Ruginseng (Ghaem Daro) capsule two times daily for 4 weeks. Intervention 2: Control group: Placebo contain maltodextrine, 500 mg, (Ghaem darou company), two

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 18-65 years Willing to participate in the study Having chronic idiopathic fatigue based on internist diagnosis

Exclusion criteria

Exclusion criteria: Pregnancy and lactation Having diabetes Having known cardiovascular disease Having known renal disease Having any types of cancer

Design outcomes

Primary

Measure	Time frame
Fatigue severity. Timepoint: Before and after 4 weeks of intervention. Method of measurement: fatigue severity scale (FSS) questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoodeh Razghei Jahromi

Shahid Beheshti University of Medical Sciences

soodehrazeghi@gmail.com+98 21 2235 7483

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026